Cargando…
mTOR pathway in colorectal cancer: an update
The mammalian target of rapamycin (mTOR) has emerged as a potential target for drug development, particularly due to the fact that it plays such a crucial role in cancer biology. In addition, next-generation mTOR inhibitors have become available, marking an exciting new phase in mTOR-based therapy....
Autores principales: | Francipane, Maria Giovanna, Lagasse, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960188/ https://www.ncbi.nlm.nih.gov/pubmed/24393708 |
Ejemplares similares
-
Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1
por: Francipane, Maria Giovanna, et al.
Publicado: (2013) -
Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure
por: Francipane, Maria Giovanna, et al.
Publicado: (2019) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
mTOR Pathways in Cancer and Autophagy
por: Paquette, Mathieu, et al.
Publicado: (2018)